Cita APA (7a ed.)

K, S., & N, v. B. (2014). Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib. Dove Medical Press.

Cita Chicago Style (17a ed.)

K, Shoumariyeh, y von Bubnoff N. Long-term Safety and Efficacy of Dasatinib in the Treatment of Chronic-phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib. Dove Medical Press, 2014.

Cita MLA (8a ed.)

K, Shoumariyeh, y von Bubnoff N. Long-term Safety and Efficacy of Dasatinib in the Treatment of Chronic-phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib. Dove Medical Press, 2014.